Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors
- PMID: 19204768
- PMCID: PMC2535897
- DOI: 10.2450/2007.0020-07
Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors
Abstract
Background: Cardiovascular diseases are among the most frequent causes of mortality and morbidity in industrialised countries. The identification of subjects at high risk of cardiovascular diseases is one of the main aims of individual primary prevention programmes and is the essential background for instituting interventions aimed at reducing modifiable risk factors, from lifestyle changes to pharmacological interventions. DONORS AND METHOD: In order to evaluate the absolute global risk of cardiovascular disease in the population of blood donors of the Transfusion and Immunohaematology Centre of the Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena of Milan, we used the absolute global cardiovascular risk (CVR) score of the Progetto Cuore. Between September 2004 and June 2006, 11,093 blood donors were evaluated for their suitability for donating blood. The criteria for inclusion in the calculation of the individual values of the absolute global CVR score were: age between 35 and 65 years old, fasted for at least 12 hours, and no previous reported or diagnosed cardiovascular episodes. Each donor was also asked to provide written informed consent to participation in the study. THE POPULATION OF BLOOD DONORS WAS DIVIDED INTO FOUR GROUPS ACCORDING TO THEIR CVR SCORE: CVR < 3%, CVR between 3% and 10%, CVR between 10% and 20%; CVR above 20%. The characteristics of the population were analysed subdividing the subjects according to age and gender.
Results: Although most of the blood donors belonged to the group with low CVR, it was nevertheless possible to identify a group of donors with high CVR.
Conclusions: It is to be hoped that CVR is calculated ever more widely in the population of blood donors in order to identify individuals at high CVR and also with the aim of reducing the levels of risk factors in the population with low or moderate CVR.
Keywords: Cardiovascular prevention; absolute global cardiovascular risk; blood donors.
Similar articles
-
Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.Blood Transfus. 2010 Jul;8(3):155-8. doi: 10.2450/2009.0097-09. Blood Transfus. 2010. PMID: 20671874 Free PMC article.
-
[Rare diseases: the model of Ospedale Maggiore Policlinico IRCCS Mangiagalli Regina Elena].Ann Ig. 2008 May-Jun;20(3):233-42. Ann Ig. 2008. PMID: 18693401 Italian.
-
[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. G Ital Cardiol (Rome). 2008. PMID: 18773746 Review. Italian.
-
Risk-adjusted versus overall blood pressure control rate for identifying the need for intensified cardiovascular risk reduction: lessons from a cross-sectional study.Eur J Prev Cardiol. 2013 Dec;20(6):972-9. doi: 10.1177/2047487312472079. Epub 2012 Dec 19. Eur J Prev Cardiol. 2013. PMID: 23253744 Clinical Trial.
-
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.Expert Rev Gastroenterol Hepatol. 2015 May;9(5):629-50. doi: 10.1586/17474124.2015.965143. Epub 2014 Oct 20. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25327387 Review.
Cited by
-
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.BMC Cardiovasc Disord. 2019 Jul 26;19(1):177. doi: 10.1186/s12872-019-1157-5. BMC Cardiovasc Disord. 2019. PMID: 31349819 Free PMC article.
-
Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver Transplant Recipients.Healthcare (Basel). 2024 Jun 8;12(12):1165. doi: 10.3390/healthcare12121165. Healthcare (Basel). 2024. PMID: 38921280 Free PMC article.
-
Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.Blood Transfus. 2010 Jul;8(3):155-8. doi: 10.2450/2009.0097-09. Blood Transfus. 2010. PMID: 20671874 Free PMC article.
-
The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.Ann Transl Med. 2016 May;4(10):189. doi: 10.21037/atm.2016.03.58. Ann Transl Med. 2016. PMID: 27294085 Free PMC article.
-
Health promotion for blood donors: A scoping review.Public Health Pract (Oxf). 2025 Mar 22;9:100604. doi: 10.1016/j.puhip.2025.100604. eCollection 2025 Jun. Public Health Pract (Oxf). 2025. PMID: 40256568 Free PMC article. Review.
References
-
- Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. - PubMed
-
- Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study, 16 years follow up. In: Kannell WB, Gordon T, editors. The Framingham study. An epidemiological investigation of cardiovascular diseases. Section 26. US Government Printing Office n° 0–414–297; Washington DC: 1971.
-
- Anderson KM, Wilson PWF, Odell PM, et al. An updated coronary risk profile. A statment for health professionals. Circulation. 1991;83:356–62. - PubMed
-
- Giampaoli S, Palmieri L, Mattiello A, et al. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis. 2005;15:79–85. - PubMed
-
- Grundy SM, Bazzarre T, Cleeman J, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Circulation. 2000;101:e3–e11. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials